Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Gastrointestinal Neoplasms × Palonosetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 11 Nausea 5 Neoplasms 2 Breast Neoplasms 2 Solid Tumors 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1 Breast Neoplasms, Male 1

Interventions

Bevacizumab 5 Leucovorin 4 Irinotecan 4 Fluorouracil 4 Capecitabine 3 Oxaliplatin 2 Drug Therapy 2 trifluridine tipiracil drug combination 1 romiplostim 1 napabucasin 1 entecavir 1 encorafenib 1 apatinib 1 abelacimab 1 Sunitinib 1 Specimen Handling 1 S-1 plus cisplatin 1 Radiosurgery 1 Palonosetron 1 Oviposition 1 Nutrition Assessment 1 Nucleotides 1 Methylphenidate 1 Memantine 1 Melatonin 1 Magnetic Resonance Spectroscopy 1 MAA868 1 Levoleucovorin 1 IDRX-42 1 Glutamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03674294 2023-02-08

CINV

Sun Yat-sen University

Phase 3 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡